http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012044783-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4774c229e18934fc36eb1bbd0188e0f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6341d3f8d3f41b61d5e4487b7223905b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcce63b212704284382017151a108fc4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-32
filingDate 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60552884716ee9871a2a3c9dfb95cd1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8f8768e40580d58cdad0daacf81be6
publicationDate 2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012044783-A8
titleOfInvention Method of achieving a thymosin beta 4 concentration in a human patient
abstract The present invention provides embodiments which involve methods of providing a predetermined concentration of thymosin beta 4 (TB4) at a predetermined time, t, in a body portion of a live human patient. The methods can include determining a thymosin beta 4 treatment dosage (D) using Formula I: C = (A)D ⋅ t -B , wherein C is the predetermined concentration at time t, in ng/mL, D is the dosage of thymosin beta 4 administered in mg, t is the time elapsed after administration of dosage D in hours, A is about 30 to about 38, and B is about 0.5 to about 1; and administering the dosage (D) of thymosin beta 4 to the patient. Formula I may be, for example, C=(35.6)D ⋅ t -0.754 (Formula II).
priorityDate 2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81814
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID793949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28280
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID781334
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7114
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408047
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID399438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16132341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422601108

Total number of triples: 28.